Trials / Active Not Recruiting
Active Not RecruitingNCT06199700
Esketamine for the Treatment of Rett Syndrome
An Exploratory Trial of Esketamine for the Treatment of Rett Syndrome
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Children's Hospital of Fudan University · Academic / Other
- Sex
- Female
- Age
- 5 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this interventional study is to learn about the efficacy and safety of Esketamine for treating children with Rett syndrome (RTT). The main questions it aims to answer are: * whether Esketamine treatment is effective in improving symptom severity for RTT. * whether Esketamine is safe in the treatment of RTT. Participants will receive a weekly intravenous infusion of Esketamine for five weeks and will be assessed for disease severity and drug safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esketamine hydrochloride | Intravenous infusion of Ketamine |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2024-04-04
- Completion
- 2025-05-01
- First posted
- 2024-01-10
- Last updated
- 2025-02-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06199700. Inclusion in this directory is not an endorsement.